As a class of drugs, GLP-1s have been shown to result in weight loss.[2] Common side effects of GLP-1s include nausea, vomiting, diarrhea, constipation, injection site reactions, headache, hypoglycemia, dyspepsia, fatigue, dizziness, abdominal pain, and gastroenteritis.[1-4] All GLP-1s carry a boxed warning for the risk of thyroid c-cell tumors and a contraindication for a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
O.WoetmannA.dumN.Menn BonefeldC.et al
This is thought to be through the sensitization of the Akt/mTOR signaling pathway, which is a key regulator of protein synthesis in muscle cells
Moderna Therapeutics, Pfizer-BioNTech and Johnson & Johnson break down participation in their COVID-19 vaccine trials by ethnicity, gender and race
Les mdecins doivent valuer chaque patient individuellement, insiste le Dr Wharton